• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液中的纤维蛋白-纤维蛋白原降解产物

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

作者信息

Brueton M J, Breeze G R, Stuart J

出版信息

J Clin Pathol. 1976 Apr;29(4):341-4. doi: 10.1136/jcp.29.4.341.

DOI:10.1136/jcp.29.4.341
PMID:932226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC476059/
Abstract

An increase in low molecular weight fibrin-fibrinogen degradation products (FDP) was demonstrated in cerebrospinal fluid (CSF) from 17 of 18 patients with bacterial or viral meningitis compared with 29 patients without meningitis. The CSF also showed an increase in coagulation proteins of molecular weight less than 90000 (factors VII, IX, and plasminogen) but did not contain fibrinogen (MW 340000) or plasminogen activator. It is concluded that low molecular weight FDP in the CSF in infective meningitis result from leakage through a damaged blood-CSF barrier rather than from local digestion of fibrin deposited on the meninges.

摘要

与29例无脑膜炎的患者相比,18例细菌性或病毒性脑膜炎患者中有17例的脑脊液(CSF)中低分子量纤维蛋白 - 纤维蛋白原降解产物(FDP)增加。脑脊液中分子量小于90000的凝血蛋白(因子VII、IX和纤溶酶原)也有所增加,但不含纤维蛋白原(分子量340000)或纤溶酶原激活物。结论是,感染性脑膜炎患者脑脊液中的低分子量FDP是由于受损的血脑屏障渗漏所致,而非脑膜上沉积的纤维蛋白的局部消化。

相似文献

1
Fibrin-fibrinogen degradation products in cerebrospinal fluid.脑脊液中的纤维蛋白-纤维蛋白原降解产物
J Clin Pathol. 1976 Apr;29(4):341-4. doi: 10.1136/jcp.29.4.341.
2
Coagulation and fibrinolytic activity of cerebrospinal fluid.脑脊液的凝血和纤溶活性。
J Clin Pathol. 1978 May;31(5):488-92. doi: 10.1136/jcp.31.5.488.
3
[FDP levels in the cerebrospinal fluid are elevated in patients with meningitis].脑膜炎患者脑脊液中的FDP水平升高。
Rinsho Byori. 1991 Jun;39(6):651-5.
4
Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).动脉瘤性蛛网膜下腔出血后血液和脑脊液中的凝血与纤溶:氨甲环酸(AMCA)的作用
Acta Neurochir (Wien). 1981;56(1-2):25-38. doi: 10.1007/BF01400969.
5
Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis.肺炎球菌性脑膜炎患者脑脊液中的纤维蛋白降解产物
J Neurol Neurosurg Psychiatry. 1979 Sep;42(9):843-6. doi: 10.1136/jnnp.42.9.843.
6
[In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].[体外研究以阐明因炎症和出血而改变且具有病理性蛋白值的脑脊液中的纤溶活性]
Psychiatr Neurol Med Psychol (Leipz). 1977 Aug;29(8):465-73.
7
[Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
Med Clin (Barc). 1980 Nov 10;75(8):338-41.
8
[In-vitro experiments on the clarification of the fibrinolytic activity in normal cerebrospinal fluid].[关于正常脑脊液中纤溶活性的体外实验]
Psychiatr Neurol Med Psychol (Leipz). 1977 May;29(5):275-84.
9
Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.蛛网膜下腔出血后脑脊液中纤维蛋白/纤维蛋白原降解产物的来源。
J Neurosurg. 1985 Oct;63(4):573-7. doi: 10.3171/jns.1985.63.4.0573.
10
Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.动脉瘤破裂所致蛛网膜下腔出血患者脑脊液中纤维蛋白和纤维蛋白原降解产物(FDP)的监测。55例报告。
J Neurosurg Sci. 1994 Jun;38(2):77-86.

引用本文的文献

1
Bacterial Aggregation in Cerebral Spinal Fluid: The Extent it Occurs and the Clinical Ramifications.脑脊液中的细菌聚集:发生的程度及其临床意义。
Curr Microbiol. 2024 Jun 4;81(7):205. doi: 10.1007/s00284-024-03727-4.
2
The FDP/FIB Ratio and Blood FDP Level May Be Related to Seizures After Fever in Young Children.纤维蛋白降解产物/纤维蛋白原比值及血液纤维蛋白降解产物水平可能与幼儿发热后惊厥有关。
Front Pediatr. 2020 Jul 31;8:439. doi: 10.3389/fped.2020.00439. eCollection 2020.
3
Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review.血管通透性增加作为错构瘤的一个标志:病因性血管生成与炎症途径中所见机制相关还是可比?第二部分:血管生成和炎症相关分子途径、肿瘤相关巨噬细胞及可能的治疗意义:全面综述
Neurosurg Rev. 2018 Oct;41(4):931-944. doi: 10.1007/s10143-017-0837-9. Epub 2017 Mar 11.
4
Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.脑脊液压蛋白质组分析揭示与生存相关的潜在生物标志物。
J Infect Dis. 2010 Aug 15;202(4):542-50. doi: 10.1086/654819.
5
Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血后脑脊液中氨甲环酸(AMCA)及纤维蛋白/纤维蛋白原降解产物的测定
Acta Neurochir (Wien). 1981;58(1-2):1-13. doi: 10.1007/BF01401679.
6
Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).动脉瘤性蛛网膜下腔出血后血液和脑脊液中的凝血与纤溶:氨甲环酸(AMCA)的作用
Acta Neurochir (Wien). 1981;56(1-2):25-38. doi: 10.1007/BF01400969.
7
Childhood bacterial meningitis.儿童细菌性脑膜炎
J Neurol Neurosurg Psychiatry. 1982 Feb;45(2):186. doi: 10.1136/jnnp.45.2.186.
8
Coagulation and fibrinolytic activity of cerebrospinal fluid.脑脊液的凝血和纤溶活性。
J Clin Pathol. 1978 May;31(5):488-92. doi: 10.1136/jcp.31.5.488.
9
Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis.肺炎球菌性脑膜炎患者脑脊液中的纤维蛋白降解产物
J Neurol Neurosurg Psychiatry. 1979 Sep;42(9):843-6. doi: 10.1136/jnnp.42.9.843.
10
The nitroblue-tetrazolium test in granulocytes of the cerebrospinal fluid--methodological problems.
Infection. 1979;7(1):10-3. doi: 10.1007/BF01640548.

本文引用的文献

1
New one-stage procedures for the quantitative determination of prothrombin and labile factor.凝血酶原和不稳定因子定量测定的新型一步法
Am J Clin Pathol. 1950 Mar;20(3):233-40. doi: 10.1093/ajcp/20.3.233.
2
The fibrin plate method for estimating fibrinolytic activity.用于评估纤维蛋白溶解活性的纤维蛋白平板法。
Arch Biochem Biophys. 1952 Oct;40(2):346-51. doi: 10.1016/0003-9861(52)90121-5.
3
Effect of mental stress on the fibrinolytic reactivity to exercise.精神应激对运动纤溶反应的影响。
Br Med J. 1967 May 27;2(5551):545-8. doi: 10.1136/bmj.2.5551.545.
4
Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.人血清中纤维蛋白原裂解产物的定量测定及其与诊断和治疗的关系
Blood. 1966 Jul;28(1):1-18.
5
Antifibrinolytic therapy for intracranial aneurysms.颅内动脉瘤的抗纤溶治疗。
J Neurosurg. 1968 Jan;28(1):21-3. doi: 10.3171/jns.1968.28.1.0021.
6
Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.抗纤维蛋白溶解剂(氨甲环酸)在颅内动脉瘤破裂治疗中的应用。
Postgrad Med J. 1971 Apr;47(546):199-200. doi: 10.1136/pgmj.47.546.199.
7
Angiographic manifestations in cerebral inflammatory disease.
Radiology. 1971 Mar;98(3):595-604. doi: 10.1148/98.3.595.
8
Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.纤维蛋白溶解与蛛网膜下腔出血。氨甲环酸的抑制作用。一项临床研究。
Acta Neurol Scand. 1972;48(4):393-402. doi: 10.1111/j.1600-0404.1972.tb07561.x.
9
A technique for routine evaluation of plasminogen in humans during streptokinase therapy.一种在链激酶治疗期间对人体纤溶酶原进行常规评估的技术。
Acta Haematol. 1965 Nov;34(5):305-20. doi: 10.1159/000209454.
10
Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.精神科病房收治患者脑脊液中的纤维蛋白-纤维蛋白原降解产物
J Neurol Neurosurg Psychiatry. 1974 Mar;37(3):249-51. doi: 10.1136/jnnp.37.3.249.